You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01377337 ↗ Sodium Bicarbonate in Cardiopulmonary Resuscitation Unknown status Rambam Health Care Campus Phase 4 2011-12-01 Out-of-hospital cardiac arrests (OHCA) account for over 60% of deaths from coronary artery disease. The annual incidence of OHCA treated by Emergency Medical Systems (EMS) is 41-89 per 100,000 population. Outcome of OHCA and cardiopulmonary resuscitation (CPR) is very poor: Less than 1/3 of the victims regain spontaneous circulation (ROSC), 40-60% of those achieving ROSC suffer significant neurological disability due to brain hypoxia and only 1.7-6.4% are discharged from the hospital. In order to minimize hypoxia time, the primary goal of CPR is to achieve return of spontaneous circulation (ROSC) as fast as possible. Metabolic (lactic) acidosis develops rapidly during CA and is considered detrimental to CPR outcome. Sodium bicarbonate (SB), a generic, commonly used acid buffer, was subjected only to a single, small, prospective controlled trial that found a trend towards improved outcome in prolonged OHCA and CPR. Another study indicated that EMS's that used SB early and often during CPR had significantly higher ROSC rates and better long-term outcome compared with EMS's that used SB more seldom and administered it late in the course of CPR. Aim of the Study: To determine whether early administration of SB during OHCA and CPR improves short-term CPR outcome.
NCT04547296 ↗ Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy Recruiting Affiliated Hospital of Qinghai University N/A 2021-04-28 A variety of reasons lead to a sharp increase in lactic acid levels in patients undergoing liver resection, while leading to hyperlactic acidemia, resulting in decreased cardiac output, elevated blood potassium, and response to catecholamines and insulin Damage, increased risk of kidney damage, poor recovery of liver function, decreased immune function, and prolonged hospital stay. Sodium bicarbonate Ringer injection does not contain lactic acid. HCO3- is metabolized by acid-base neutralization in body fluids, and 90% is CO2 The form is excreted from the body by breathing, and only 10% HCO3- is metabolized by the kidney, without the burden of liver metabolism. Physiological concentration of Cl- avoids perchloric acidosis and kidney damage; physiological concentration of Ca2+ and Mg2+ help maintain the body's electrolyte balance and reduce stress-related arrhythmia.The smooth development of this study will help refine the intraoperative fluid management strategy, improve the patient's intraoperative tissue perfusion, maintain the body's acid-base and electrolyte balance, reduce postoperative kidney damage, and improve the patient's quality of life.
NCT04547296 ↗ Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy Recruiting First Affiliated Hospital of Xinjiang Medical University N/A 2021-04-28 A variety of reasons lead to a sharp increase in lactic acid levels in patients undergoing liver resection, while leading to hyperlactic acidemia, resulting in decreased cardiac output, elevated blood potassium, and response to catecholamines and insulin Damage, increased risk of kidney damage, poor recovery of liver function, decreased immune function, and prolonged hospital stay. Sodium bicarbonate Ringer injection does not contain lactic acid. HCO3- is metabolized by acid-base neutralization in body fluids, and 90% is CO2 The form is excreted from the body by breathing, and only 10% HCO3- is metabolized by the kidney, without the burden of liver metabolism. Physiological concentration of Cl- avoids perchloric acidosis and kidney damage; physiological concentration of Ca2+ and Mg2+ help maintain the body's electrolyte balance and reduce stress-related arrhythmia.The smooth development of this study will help refine the intraoperative fluid management strategy, improve the patient's intraoperative tissue perfusion, maintain the body's acid-base and electrolyte balance, reduce postoperative kidney damage, and improve the patient's quality of life.
NCT04547296 ↗ Sodium Bicarbonate Ringer's Solution for Preventing and Treating Hyperlactacidemia During Hepatectomy Recruiting Henan Cancer Hospital N/A 2021-04-28 A variety of reasons lead to a sharp increase in lactic acid levels in patients undergoing liver resection, while leading to hyperlactic acidemia, resulting in decreased cardiac output, elevated blood potassium, and response to catecholamines and insulin Damage, increased risk of kidney damage, poor recovery of liver function, decreased immune function, and prolonged hospital stay. Sodium bicarbonate Ringer injection does not contain lactic acid. HCO3- is metabolized by acid-base neutralization in body fluids, and 90% is CO2 The form is excreted from the body by breathing, and only 10% HCO3- is metabolized by the kidney, without the burden of liver metabolism. Physiological concentration of Cl- avoids perchloric acidosis and kidney damage; physiological concentration of Ca2+ and Mg2+ help maintain the body's electrolyte balance and reduce stress-related arrhythmia.The smooth development of this study will help refine the intraoperative fluid management strategy, improve the patient's intraoperative tissue perfusion, maintain the body's acid-base and electrolyte balance, reduce postoperative kidney damage, and improve the patient's quality of life.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride

Condition Name

Condition Name for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Intervention Trials
Metabolic Acidosis 1
Ringer Bicarbonate 1
Safety 1
Shock 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Intervention Trials
Hyperlactatemia 1
Out-of-Hospital Cardiac Arrest 1
Heart Arrest 1
Death, Sudden, Cardiac 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride

Trials by Country

Trials by Country for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Location Trials
China 6
Israel 1
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride

Clinical Trial Phase

Clinical Trial Phase for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Clinical Trial Phase Trials
Not yet recruiting 2
Recruiting 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride

Sponsor Name

Sponsor Name for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Sponsor Trials
LanZhou University 1
People's Hospital of Xinjiang Uygur Autonomous Region 1
Shaanxi Provincial People's Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Calcium Chloride; Dextrose; Lactic Acid; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride
Sponsor Trials
Other 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.